Novartis Gene Therapies
Novartis is dedicated to advancing human health through innovation, focusing on developing and selling new products that contribute to human progress. With a rich history rooted in Swiss origins, the company has evolved through mergers and acquisitions, including the significant split of Alcon in 2019 to focus on innovative medicines. Novartis emphasizes a culture of innovation, scientific research, and social responsibility, aiming to address unmet medical needs worldwide.
Industries
Nr. of Employees
small (1-50)
Novartis Gene Therapies
Shanghai Pudong New Area, Zhangjiang High-Tech Park, Jinke Road 4218
Services
Program-level clinical development including protocol input, study conduct, monitoring, data review and preparation of clinical sections for regulatory submissions.
Definition and operationalization of clinical data strategies, vendor specifications and fit‑for‑purpose data packages to support analysis and regulatory submission readiness.
Provision of medical information channels and structured processes for reporting adverse events and product safety inquiries via telephone, email and online reporting.
Support for centralized research infrastructure and translational project coordination to align discovery activities with global development programs.
Program-level clinical development including protocol input, study conduct, monitoring, data review and preparation of clinical sections for regulatory submissions.
Definition and operationalization of clinical data strategies, vendor specifications and fit‑for‑purpose data packages to support analysis and regulatory submission readiness.
Provision of medical information channels and structured processes for reporting adverse events and product safety inquiries via telephone, email and online reporting.
Support for centralized research infrastructure and translational project coordination to align discovery activities with global development programs.
Expertise Areas
- Clinical trial management
- Clinical data strategy and governance
- Pharmacovigilance and safety reporting
- Regulatory submission support
Key Technologies
- Clinical data standards and pipelines
- Electronic data capture (EDC) and clinical databases
- Vendor data integration and transfer specifications
- Adaptive trial design methods
News & Updates
Novartis Achieves Major Milestone in Oncology
Novartis announced a significant breakthrough in cancer treatment, advancing its leadership in oncology.
Sustainability Initiatives in China
Novartis China launches new environmental and social responsibility programs.
Novartis' Commitment to Innovation and Sustainability
An in-depth look at Novartis' strategies for innovation and social responsibility.
Global Recognition for Novartis' Workplace Culture
Awards and recognitions received for fostering an inclusive and innovative work environment.
Top Employer Award 2023
Recognized as a top employer for diversity and employee satisfaction.
Innovation in Healthcare Award
Received for groundbreaking research in rare diseases.
Novartis Achieves Major Milestone in Oncology
Novartis announced a significant breakthrough in cancer treatment, advancing its leadership in oncology.
Sustainability Initiatives in China
Novartis China launches new environmental and social responsibility programs.
Novartis' Commitment to Innovation and Sustainability
An in-depth look at Novartis' strategies for innovation and social responsibility.
Global Recognition for Novartis' Workplace Culture
Awards and recognitions received for fostering an inclusive and innovative work environment.
Top Employer Award 2023
Recognized as a top employer for diversity and employee satisfaction.
Innovation in Healthcare Award
Received for groundbreaking research in rare diseases.